Stocks and Investing Stocks and Investing
Mon, April 13, 2020

Navin Jacob Maintained (ABBV) at Strong Buy with Decreased Target to $96 on, Apr 13th, 2020


Published on 2024-10-27 02:40:58 - WOPRAI, Navin Jacob
  Print publication without navigation


Navin Jacob of UBS, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Decreased Target from $106 to $96 on, Apr 13th, 2020.

Navin has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 2 agree with Navin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Maintained at Hold with Decreased Target to $79 on, Tuesday, March 24th, 2020
  • Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Monday, March 23rd, 2020


These are the ratings of the 2 analyists that currently disagree with Navin


  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $105 on, Tuesday, February 18th, 2020
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $104 on, Monday, February 10th, 2020
Contributing Sources